ACG Films Expands its Portfolio of Ultra-High Barrier Blister Films
The films are now available in three options of varying thickness for added protection against moisture and oxygen.
ACG Films, part of the ACG Group, announced on Dec. 16, 2020 that it has expanded its UltraSafe portfolio of ultra-high barrier blister films.
The films are now available in three options of varying thickness for added protection against moisture and oxygen, ACG said in a company press release. The new films include the UltraSafe Dupac, which is made up of polyvinyl chloride (PVC) and polyvinylidene chloride (PVdC), the UltraSafe Tripac, which is comprised of those two substrates plus a layer of polyethylene in between, and Core, which features a single layer of PVdC between two layers of PVC.
Benefits of the films include:
- Premium barrier protection to prevent the loss or unwanted addition of aroma and flavor
- Seal integrity at high speeds with no special tooling
- The ability to reduce pack sizes or increase pill density without enlarging the package
- No need for specialized infrastructure.
The films also offer processing advantages. They can be produced using tools or molds designed for PVC or regular PVDC coated films. The material can generate angle cavities that are steeper and deeper than those generated by conventional strip/aluminum blisters. It can also mitigate blister curling issues post-thermoforming and enable better production control.
Source: ACG
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
